Drugs / GNR-084
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04601584 | Oct 2020 → Feb 2025 | precursor B-cell acute lymphoblastic leukemia | AO GENERIUM | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GNR-084 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04601584 ↗ |
| Route | Intravenous | “0.01 ng/kg 6-hours intravenous infusion once a week; 4 doses per cycle, up to 5 cycles” NCT04601584 ↗ |